Copyright
©The Author(s) 2017.
World J Gastroenterol. Mar 7, 2017; 23(9): 1618-1626
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1618
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1618
Table 3 Drug-drug interactions identified per fibrosis stage
| Fibrosis stage | n = 664 | Total number of medications | Total number of interactions n (%) | Average number of medications per patient | Average number of interactions per patient |
| Minimal fibrosis (Stage 0-2) | 232 | 1508 | 249 (16.5) | 6.50 | 1.07 |
| Advanced fibrosis (Stage 3) | 72 | 575 | 91 (15.8) | 7.99 | 1.26 |
| Cirrhosis (Stage 4) | 341 | 3066 | 425 (13.8) | 8.99 | 1.25 |
- Citation: Langness JA, Nguyen M, Wieland A, Everson GT, Kiser JJ. Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions. World J Gastroenterol 2017; 23(9): 1618-1626
- URL: https://www.wjgnet.com/1007-9327/full/v23/i9/1618.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i9.1618